AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TEICOPLANINE
8 registrations across 3 African markets— 2 active
Markets with TEICOPLANINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TICOPEX 200 MG IM / IV / IP POUDRE POUR SOLUTION INJECTABLE BOITE DE 1 FLACON DE POUDRE | 🇨🇮Côte d'Ivoire | LABORATOIRE MS PHARMA | expired | Feb 2024 |
| TEICO Pdre p.prep.injectable / 400 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Oct 2018 |
| TEICO Pdre p.prep.injectable / 200 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Oct 2018 |
| TARGOPLANIN Pdre p.prep.injectable / 200 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Feb 2016 |
| TEICO Pdre p.prep.injectable / 200 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2010 |
| TEICO Pdre p.prep.injectable / 400 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2010 |
| TARGOCID POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| TARGOCID POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
TEICOPLANINE in Africa — Regulatory Overview
TEICOPLANINE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 2 (25%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.